What you’ll eventually see with drugs is they all use a revolving door IP scam to keep patent rights as long as possible and in most cases increases harm. It’s a way to make as much lazy money as possible in pharmaceuticals because it requires bureaucracy to profit, not ingenuity. In this case Sanofi and GSK are playing off each other to get these shots into infants instead of 2 year olds when the shot is normally administered. These companies just made a Covid “vaccine” together in 2022, and GSK just hired the head of Sanofis R&D on vaccines this year.
What you’ll eventually see with drugs is they all use a revolving door IP scam to keep patent rights as long as possible and in most cases increases harm. It’s a way to make as much lazy money as possible in pharmaceuticals because it requires bureaucracy to profit, not ingenuity. In this case Sanofi and GSK are playing off each other to get these shots into infants instead of 2 year olds when the shot is normally administered. These companies just made a Covid “vaccine” together in 2022, and GSK just hired the head of Sanofis R&D on vaccines this year.